Researchers have conducted a trial comparing a dual-hormone artificial pancreas with conventional diabetes treatment using an insulin pump and showed improved glucose levels and lower risks of hypoglycemia. Their results can have a great impact on the treatment of type 1 diabetes by accelerating the development of the external artificial pancreas.